Safety and Immunogenicity of a Shigella Bivalent Conjugate Vaccine (ZF0901) in 3-Month- to 5-Year-Old Children in China

No licensed Shigella vaccine is presently available globally. A double-blinded, randomized, placebo-controlled, age descending phase II clinical trial of a bivalent conjugate vaccine was studied in China. The vaccine ZF0901 consisted of O-specific polysaccharides purified and detoxified from lipopol...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Yi, Fang, Wenjian, Li, Hong, Chen, Junji, Hu, Xiaohua, Wang, Bin, Feng, Zhengli, Shi, Honghua, He, Ying, Huang, Dong, Mo, Zhaojun, Ye, Qiang, Du, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780113/
https://www.ncbi.nlm.nih.gov/pubmed/35062694
http://dx.doi.org/10.3390/vaccines10010033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780113/
https://www.ncbi.nlm.nih.gov/pubmed/35062694
http://dx.doi.org/10.3390/vaccines10010033

Ejemplares similares